- Report
- February 2024
- 140 Pages
Global
From €4693EUR$4,750USD£3,906GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Report
- September 2024
- 250 Pages
Global
From €4939EUR$4,999USD£4,111GBP
- Report
- May 2024
- 200 Pages
Global
From €4101EUR$4,150USD£3,413GBP
- Report
- May 2023
- 250 Pages
Global
From €3947EUR$3,995USD£3,285GBP
- Report
- August 2023
- 235 Pages
Global
From €4912EUR$5,145USD£3,950GBP
- Report
- October 2020
- 222 Pages
Global
From €2964EUR$3,000USD£2,467GBP
- Report
- June 2023
- 840 Pages
Global
From €3557EUR$3,600USD£2,961GBP
- Report
- July 2022
- 600 Pages
Global
From €3261EUR$3,300USD£2,714GBP
- Report
- October 2019
- 170 Pages
Global
From €2569EUR$2,600USD£2,138GBP
- Report
- March 2018
- 255 Pages
Global
From €2569EUR$2,600USD£2,138GBP
- Report
- July 2021
- 155 Pages
Global
From €2717EUR$2,750USD£2,262GBP
€5434EUR$5,500USD£4,523GBP
- Report
- February 2022
- 199 Pages
Global
From €5187EUR$5,250USD£4,318GBP
- Report
- August 2023
- 85 Pages
United States
From €4792EUR$4,850USD£3,989GBP
- Report
- July 2023
- 130 Pages
Global
From €5879EUR$5,950USD£4,893GBP
- Report
- November 2022
- 200 Pages
Global
From €5879EUR$5,950USD£4,893GBP
- Drug Pipelines
- January 2018
- 13 Pages
Global
From €9881EUR$10,000USD£8,224GBP
- Report
- September 2022
- 134 Pages
From €2075EUR$2,100USD£1,727GBP
€2964EUR$3,000USD£2,467GBP
- Report
- September 2022
- 150 Pages
Middle East, Africa
From €2075EUR$2,100USD£1,727GBP
€2964EUR$3,000USD£2,467GBP
- Report
- September 2022
- 157 Pages
Europe
From €2075EUR$2,100USD£1,727GBP
€2964EUR$3,000USD£2,467GBP
The Cancer Vaccines market is a rapidly growing sector of the healthcare industry. It is focused on the development of vaccines to prevent and treat cancer. These vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells. The goal is to reduce the risk of cancer recurrence and improve the quality of life for cancer patients.
The Cancer Vaccines market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies are involved in the research, development, and production of cancer vaccines. They are also involved in clinical trials to test the safety and efficacy of these vaccines.
Some of the major players in the Cancer Vaccines market include Merck, GlaxoSmithKline, Pfizer, Sanofi, and Johnson & Johnson. These companies are actively involved in the development of cancer vaccines and are working to bring new treatments to the market. Show Less Read more
